Cedrus LLC Thermo Fisher Scientific Inc. Transaction History

Cedrus LLC

$200 Billion
Q2 2024

A detailed history of Cedrus LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Cedrus LLC holds 472 shares of TMO stock, worth $288,547. This represents 0.13% of its overall portfolio holdings.

Number of Shares

472

Previous 515 8.35%

Holding current value

$288,547

Previous $299 Million 12.8%

% of portfolio

0.13%

Previous 0.16%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$541.52 - $599.02 $23,285 - $25,757	-43 Reduced 8.35%	472 $261 Million
Q1 2024 Apr 15, 2024	SELL	$528.82 - $599.43 $15,335 - $17,383	-29 Reduced 5.33%	515 $299 Million
Q4 2023 Jan 26, 2024	SELL	$431.41 - $532.94 $15,099 - $18,652	-35 Reduced 6.04%	544 $289 Million
Q3 2023 Jan 24, 2024	SELL	$498.29 - $574.41 $52,818 - $60,887	-106 Reduced 15.47%	579 $293 Million
Q2 2023 Jan 24, 2024	SELL	$508.46 - $591.13 $8,135 - $9,458	-16 Reduced 2.28%	685 $357 Million
Q1 2023 Jan 24, 2024	SELL	$535.0 - $604.82 $10,165 - $11,491	-19 Reduced 2.64%	701 $404 Million
Q4 2022 Jan 19, 2024	SELL	$484.71 - $571.37 $6,785 - $7,999	-14 Reduced 1.91%	720 $396 Million
Q3 2022 Jan 19, 2024	BUY	$507.19 - $604.49 $28,402 - $33,851	56 Added 8.26%	734 $372 Million
Q2 2022 Jan 19, 2024	BUY	$500.9 - $612.21 $13,023 - $15,917	26 Added 3.99%	678 $368 Million
Q1 2022 Jan 19, 2024	BUY	$524.0 - $644.92 $40,348 - $49,658	77 Added 13.39%	652 $385 Million
Q4 2021 Jan 19, 2024	BUY	$569.0 - $667.24 $327,175 - $383,663	575 New	575 $384 Million

Others Institutions Holding TMO

# of Institutions

2,775

Shares Held

340M

Call Options Held

1.42M

Put Options Held

2.15M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $240B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedrus LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedrus LLC with notifications on news.

Account